Stock TRUMY TERUMO CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Terumo Corporation OTC Markets

Equities

TRUMY

US88156J1051

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 20:59:59 20/06/2024 BST 		5-day change 1st Jan Change
16.24 USD -0.98% Intraday chart for Terumo Corporation -5.81% -0.43%
06-11 Japan's Nikkei rises on US stocks, heavyweight chip shares RE
05-28 Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview?? Monitoring System CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,505,187 2,796,910 3,021,411 2,816,528 2,661,180 3,849,258 - -
Enterprise Value (EV) 1 2,607,340 2,876,206 3,081,210 2,837,273 2,705,795 4,078,883 3,796,277 3,723,959
P/E ratio 31.1 x 32.6 x 39.1 x 31.7 x 30 x 38.2 x 30.4 x 26.4 x
Yield 0.8% 0.75% 0.73% 0.91% 1.12% 0.81% 0.99% 1.1%
Capitalization / Revenue 4.18 x 4.45 x 4.92 x 4 x 3.24 x 4.4 x 3.88 x 3.61 x
EV / Revenue 4.35 x 4.57 x 5.02 x 4.03 x 3.3 x 4.42 x 3.83 x 3.5 x
EV / EBITDA 17.3 x 17.6 x 20.2 x 16.2 x 14.4 x 18.8 x 15.5 x 13.7 x
EV / FCF 79.7 x 103 x 69.6 x 45 x 46.3 x 60.1 x 33.5 x 32.5 x
FCF Yield 1.26% 0.97% 1.44% 2.22% 2.16% 1.66% 2.98% 3.08%
Price to Book 3.6 x 3.71 x 3.53 x 2.78 x 2.4 x 3.05 x 2.74 x 2.69 x
Nbr of stocks (in thousands) 1,482,359 1,503,715 1,511,083 1,512,636 1,489,189 1,484,767 - -
Reference price 2 1,690 1,860 2,000 1,862 1,787 2,592 2,592 2,592
Announcement Date 09/05/19 18/05/20 12/05/21 12/05/22 15/05/23 14/05/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 599,481 628,897 613,842 703,303 820,209 921,863 990,938 1,065,284
EBITDA 1 150,672 162,969 152,318 174,842 187,570 216,841 245,049 272,344
EBIT 1 106,637 110,611 98,386 115,960 117,332 140,096 166,903 191,908
Operating Margin 17.79% 17.59% 16.03% 16.49% 14.31% 15.2% 16.84% 18.01%
Earnings before Tax (EBT) 1 102,709 106,466 97,060 114,501 116,137 140,829 167,942 191,835
Net income 1 79,470 85,211 77,268 88,813 89,325 106,374 126,748 145,768
Net margin 13.26% 13.55% 12.59% 12.63% 10.89% 11.54% 12.79% 13.68%
EPS 2 54.35 56.98 51.16 58.72 59.50 71.50 85.29 98.21
Free Cash Flow 1 32,726 27,969 44,277 63,013 58,415 67,904 113,251 114,600
FCF margin 5.46% 4.45% 7.21% 8.96% 7.12% 7.37% 11.43% 10.76%
FCF Conversion (EBITDA) 21.72% 17.16% 29.07% 36.04% 31.14% 31.32% 46.22% 42.08%
FCF Conversion (Net income) 41.18% 32.82% 57.3% 70.95% 65.4% 63.84% 89.35% 78.62%
Dividend per Share 2 13.50 14.00 14.50 17.00 20.00 22.00 25.67 28.62
Announcement Date 09/05/19 18/05/20 12/05/21 12/05/22 15/05/23 14/05/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 307,278 283,296 172,921 344,637 178,845 179,821 197,340 205,976 403,316 214,677 202,216 215,252 228,622 443,874 239,077 238,912 241,745 250,140 259,690 257,431
EBITDA 1 - - - - - - - - - - - - - - - 55,177 62,112 63,149 59,607 60,532
EBIT 1 59,150 41,824 29,624 65,857 28,598 21,505 30,427 25,550 55,977 37,537 23,121 29,644 36,848 66,492 39,027 34,577 39,994 43,350 45,026 42,014
Operating Margin 19.25% 14.76% 17.13% 19.11% 15.99% 11.96% 15.42% 12.4% 13.88% 17.49% 11.43% 13.77% 16.12% 14.98% 16.32% 14.47% 16.54% 17.33% 17.34% 16.32%
Earnings before Tax (EBT) 1 58,065 40,659 29,262 65,282 27,762 21,457 29,667 24,957 54,624 37,476 24,037 29,804 36,624 66,428 39,315 35,086 40,363 43,825 43,762 43,120
Net income 1 45,711 31,842 22,093 49,988 21,708 17,117 22,398 17,923 40,321 29,859 19,145 22,549 27,543 50,092 29,805 26,477 30,328 32,806 33,779 32,630
Net margin 14.88% 11.24% 12.78% 14.5% 12.14% 9.52% 11.35% 8.7% 10% 13.91% 9.47% 10.48% 12.05% 11.29% 12.47% 11.08% 12.55% 13.11% 13.01% 12.68%
EPS 2 30.72 21.10 14.60 33.06 14.36 11.32 14.80 11.88 26.68 19.94 12.88 15.14 18.50 33.64 20.03 17.84 20.26 21.57 23.66 21.92
Dividend per Share 2 7.000 7.000 8.000 8.000 - 9.000 - - 9.500 - - - 11.00 11.00 - 11.00 - 13.00 - 13.00
Announcement Date 07/11/19 05/11/20 04/11/21 04/11/21 09/02/22 12/05/22 09/08/22 10/11/22 10/11/22 09/02/23 15/05/23 09/08/23 14/11/23 14/11/23 07/02/24 14/05/24 - - - -
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 102,153 79,296 59,799 20,745 44,615 26,965 - -
Net Cash position 1 - - - - - - 52,981 125,299
Leverage (Debt/EBITDA) 0.678 x 0.4866 x 0.3926 x 0.1186 x 0.2379 x 0.1244 x - -
Free Cash Flow 1 32,726 27,969 44,277 63,013 58,415 67,904 113,251 114,600
ROE (net income / shareholders' equity) 12.7% 11.7% 9.6% 9.5% 8.4% 8.7% 9.32% 10.3%
ROA (Net income/ Total Assets) 9.34% 9.01% 7.49% 8.11% 7.55% 8.2% 7.56% 7.84%
Assets 1 851,025 945,282 1,031,943 1,095,564 1,182,898 1,296,781 1,676,032 1,858,417
Book Value Per Share 2 470.0 502.0 567.0 669.0 746.0 894.0 946.0 963.0
Cash Flow per Share 2 84.50 92.00 86.90 97.70 106.0 123.0 132.0 144.0
Capex 1 60,845 89,510 77,208 69,230 75,774 78,426 90,558 86,966
Capex / Sales 10.15% 14.23% 12.58% 9.84% 9.24% 8.51% 9.14% 8.16%
Announcement Date 09/05/19 18/05/20 12/05/21 12/05/22 15/05/23 14/05/24 - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Terumo Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,592 JPY
Average target price
3,093 JPY
Spread / Average Target
+19.31%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.18% 181B
MEDTRONIC PLC Stock Medtronic plc
-2.68% 105B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-2.23% 67.55B
DEXCOM, INC. Stock DexCom, Inc.
-6.46% 46.39B
HOYA CORPORATION Stock Hoya Corporation
+4.82% 40.93B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+20.09% 31.63B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.67% 23.46B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-12.70% 21.95B
STERIS PLC Stock STERIS plc
-0.25% 21.4B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 4543 Stock
  4. TRUMY Stock
  5. Financials Terumo Corporation